-
VC Taskforce
Distance: 1.7 Mi2225 E Bayshore Rd
94303-3220 East Palo Alto -
Biros
Distance: 2.1 Mi660 Middlefield Rd
94301 Palo Alto -
Hercules Technology Growth Capital
Distance: 2.7 Mi4 Square 200 3000 El Camino Real
94306 Palo Alto -
International Venture Fund
Distance: 2.5 MiPO Box 7355
94026 Menlo Park -
Abingworth Management
Distance: 2.8 Mi2465 E Bayshore Rd Ste 348
94303 Palo Alto
Website Links
Description
This press release contains "forward-looking statements" within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Statements that are not historical facts are forward-looking statements.
Our Difference We have decades of experience in developing and growing life sciences companies. We're deeply engaged with our companies, helping them mitigate risk at all stages of their evolution. We leverage the track record and experience of Mir Imran who has founded more than 20 life sciences companies, 15 of which have achieved exits either through acquisitions or IPOs. We work with our companies to reduce risk - including technical, regulatory & clinical, reimbursement, Intellectual Property, and competitive - and chart the best path forward.
"Body Media is the pioneer in developing wearable body monitoring systems for various health applications. We are building an exciting company, and we need the best minds around the table to take our company forward. The InCube Ventures team is engaged, and incredibly supportive and willing to help in any way they can to support our success.
Nfocus is a neurovascular company focused on treating hemorrhagic stroke with a new technology for rapidly treating aneurysms and fistulas in the brain.
Our Approach InCube Ventures is a specialized fund focusing on breakthrough innovations in medicine. Since our founding in 2008, we have funded promising healthcare innovations from obesity and chronic pain to personal health management and cardiac care. Our objective is to identify, nurture and grow companies with the potential to dramatically improve patient outcomes. We are not interested in incremental improvements, rather we look for those companies with solutions that can set new standards of care and reduce healthcare costs.